title: Pulmonary aspergillosis in a patient with rheumatoid arthritis treated by etanercept.
authors.forename: S
authors.initials: S
authors.lastname: Lassoued
authors.forename: S
authors.initials: S
authors.lastname: Sire
authors.forename: M
authors.initials: M
authors.lastname: Farny
authors.forename: T
authors.initials: T
authors.lastname: Billey
authors.forename: K
authors.initials: K
authors.lastname: Lassoued
mesh_terms: D000935:Antifungal Agents / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000150:complications / Q000188:drug therapy / Q000473:pathology; D001229:Aspergillosis, Allergic Bronchopulmonary / Q000209:etiology / Q000473:pathology / Q000628:therapy; D004322:Drainage; D000068800:Etanercept; D005260:Female; D006801:Humans; D016867:Immunocompromised Host; D007074:Immunoglobulin G / Q000627:therapeutic use*; D008875:Middle Aged; D011030:Pneumothorax; D011743:Pyrimidines / Q000627:therapeutic use; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use*; D011993:Recombinant Fusion Proteins / Q000627:therapeutic use*; D016896:Treatment Outcome; D014230:Triazoles / Q000627:therapeutic use; D065819:Voriconazole
chemical_list: D000935:Antifungal Agents; D018501:Antirheumatic Agents; D007074:Immunoglobulin G; D011743:Pyrimidines; D018124:Receptors, Tumor Necrosis Factor; D011993:Recombinant Fusion Proteins; D014230:Triazoles; D065819:Voriconazole; D000068800:Etanercept